Phase II Study of WT1 126-134 Peptide Vaccination in Combination With Adjuvants GM-CSF and KLH in AML
Phase of Trial: Phase II
Latest Information Update: 27 Feb 2017
At a glance
- Drugs INNO 305 (Primary) ; Granulocyte macrophage colony stimulating factor; Keyhole limpet haemocyanin
- Indications Acute myeloid leukaemia; Myelodysplastic syndromes
- Focus Therapeutic Use
- 03 Dec 2005 New trial record.